Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis

GLIA

Volumn 60, Issue 7, 2012, Pages 1145-1159

  Berard, Jennifer L ^a   Zarruk, Juan G ^a   Arbour, Nathalie ^b   Prat, Alexandre ^b   Yong, V Wee ^c   Jacques, Francois H ^d   Akira, Shizuo ^e   David, Samuel ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d CSSSG Hull Pavilion   (Canada)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

EAE; Lipocalin 2; Multiple sclerosis; Neuroinflammation

Indexed keywords

CD71 ANTIGEN; ERYTHROPOIETIN; FERRITIN; GAMMA INTERFERON; HEME OXYGENASE 1; INTERLEUKIN 1BETA; INTERLEUKIN 4; IRON; MATRIX METALLOPROTEINASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE SEVERITY; ENDOCYTOSIS; FEMALE; GLIA CELL; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MICROGLIA; MONOCYTE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; RELAPSE; REMISSION; SPINAL CORD; UPREGULATION;

ACUTE-PHASE PROTEINS; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INFLAMMATION; LIPOCALINS; MACROPHAGES; MICE; MICE, KNOCKOUT; MICROGLIA; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; ONCOGENE PROTEINS; SPINAL CORD; UP-REGULATION;

EID: 84860686727     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22342     Document Type: Article

References (60)

1. Baker D, Amor S. 2012. Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis. J Neuroimmunol 242: 78-83.
2. Berard JL, Wolak K, Fournier S, David S. 2010. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice. Glia 58: 434-445.
3. Brambilla R, Persaud T, Hu X, Karmally S, Shestopalov VI, Dvoriantchikova G, Ivanov D, Nathanson L, Barnum SR, Bethea JR. 2009. Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J Immunol 182: 2628-2640.
4. Chakraborty S, Kaur S, Muddana V, Sharma N, Wittel UA, Papachristou GI, Whitcomb D, Brand RE, Batra SK. 2010. Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis. Am J Gastroenterol 105: 2050-2059.
5. Chia WJ, Dawe GS, Ong WY. 2011. Expression and localization of the iron-siderophore binding protein lipocalin 2 in the normal rat brain and after kainate-induced excitotoxicity. Neurochem Int 59: 591-599.
6. Compston A, Coles A. 2008. Multiple sclerosis. Lancet 372: 1502-1517.
7. Devarajan P. 2007. Neutrophil gelatinase-associated lipocalin: New paths for an old shuttle. Cancer Ther 5: 463-470.
8. Devireddy LR, Gazin C, Zhu X, Green MR. 2005. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123: 1293-1305.
9. Devireddy LR, Teodoro JG, Richard FA, Green MR. 2001. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293: 829-834.
10. Downes CE, Crack PJ. 2010. Neural injury following stroke: Are Toll-like receptors the link between the immune system and the CNS? Br J Pharmacol 160: 1872-1888.
11. Emerson MR, LeVine SM. 2000. Heme oxygenase-1 and NADPH cytochrome P450 reductase expression in experimental allergic encephalomyelitis: An expanded view of the stress response. J Neurochem 75: 2555-2562.
12. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Collo G, Buell G, Di Virgilio F. 1997. ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 36: 1295-1301.
13. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A. 2004. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432: 917-921.
14. Flower DR. 1996. The lipocalin protein family: Structure and function. Biochem J 318 (Pt 1): 1-14.
15. Girolami EI, Bouhy D, Haber M, Johnson H, David S. 2009. Differential expression and potential role of SOCS1 and SOCS3 in Wallerian degeneration in injured peripheral nerve. Exp Neurol 2010: 173-182.
16. Gris D, Marsh DR, Oatway MA, Chen Y, Hamilton EF, Dekaban GA, Weaver LC. 2004. Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J Neurosci 24: 4043-4051.
17. Haider AS, Lowes MA, Suarez-Farinas M, Zaba LC, Cardinale I, Khatcherian A, Novitskaya I, Wittkowski KM, Krueger JG. 2008. Identification of cellular pathways of "type 1, " Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis. J Immunol 180: 1913-1920.
18. Heppner FL, Greter M, Marino D, Falsig J, Raivich G, Hövelmeyer N, Waisman A, Rülicke T, Prinz M, Priller J, Becher B, Aguzzi A. 2005. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 11: 146-152.
19. Ho MK, Springer TA. 1983. Tissue distribution, structural characterization, and biosynthesis of Mac-3, a macrophage surface glycoprotein exhibiting molecular weight heterogeneity. J Biol Chem 258: 636-642.
20. Hu J, Van Eldik LJ. 1996. S100 beta induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway. Biochim Biophys Acta 1313: 239-245.
21. Huang H, Constante M, Layoun A, Santos MM. 2009. Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood 113: 3593-3599.
22. Huitinga I, Ruuls SR, Jung S, Van Rooijen N, Hartung HP, Dijkstra CD. 1995. Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats. Clin Exp Immunol 100: 344-351.
23. Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD. 1990. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 172: 1025-1033.
24. Huseby ES, Liggitt D, Brabb T, Schnabel B, Ohlen C, Goverman J. 2001. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med 194: 669-676.
25. Hvidberg V, Jacobsen C, Strong RK, Cowland JB, Moestrup SK, Borregaard N. 2005. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett 579: 773-777.
26. Imitola J, Chitnis T, Khoury SJ. 2005. Cytokines in multiple sclerosis: From bench to bedside. Pharmacol Ther 106: 163-177.
27. Ip JP, Nocon AL, Hofer MJ, Lim SL, Muller M, Campbell IL. 2011. Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration. J Neuroinflammation 8: 124.
28. Iwakura Y, Ishigame H. 2006. The IL-23/IL-17 axis in inflammation. J Clin Invest 116: 1218-1222.
29. Kalyvas A, David S. 2004. Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron 41: 323-335.
30. Kingham PJ, Pocock JM. 2000. Microglial apoptosis induced by chromogranin A is mediated by mitochondrial depolarisation and the permeability transition but not by cytochrome c release. J Neurochem 74: 1452-1462.
31. Kjeldsen L, Cowland JB, Borregaard N. 2000. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta 1482: 272-283.
32. Lee S, Lee J, Kim S, Park JY, Lee WH, Mori K, Kim SH, Kim IK, Suk K. 2007. A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J Immunol 179: 3231-3241.
33. Lee S, Park JY, Lee WH, Kim H, Park HC, Mori K, Suk K. 2009. Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J Neurosci 29: 234-249.
34. Liu Q, Nilsen-Hamilton M. 1995. Identification of a new acute phase protein. J Biol Chem 270: 22565-22570.
35. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
36. McCandless EE, Klein RS. 2007. Molecular targets for disrupting leukocyte trafficking during multiple sclerosis. Expert Rev Mol Med 9: 1-19.
37. Mokhtarian F, McFarlin DE, Raine CS. 1984. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature 309: 356-358.
38. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, Barasch J. 2005. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 115: 610-621.
39. Mucha M, Skrzypiec AE, Schiavon E, Attwood BK, Kucerova E, Pawlak R. 2011. Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation. Proc Natl Acad Sci USA 108: 18436-18441.
40. Nair A, Frederick TJ, Miller SD. 2008. Astrocytes in multiple sclerosis: A product of their environment. Cell Mol Life Sci 65: 2702-2720.
41. Pettinelli CB, McFarlin DE. 1981. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: Requirement for Lyt 1+ 2- T lymphocytes. J Immunol 127: 1420-1423.
42. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G. 1995. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc Natl Acad Sci USA 92: 11294-11298.
43. Raivich G, Banati R. 2004. Brain microglia and blood-derived macrophages: Molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res Brain Res Rev 46: 261-281.
44. Rathore KI, Berard JL, Redensek A, Chierzi S, Lopez-Vales R, Santos M, Akira S, David S. 2011. Lipocalin 2 plays an immunomodulatory role and has detrimental effects after spinal cord injury. J Neurosci 31: 13412-13419.
45. Renno T, Taupin V, Bourbonniere L, Verge G, Tran E, De Simone R, Krakowski M, Rodriguez M, Peterson A, Owens T. 1998. Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE. Mol Cell Neurosci 12: 376-389.
46. Rubinstein T, Pitashny M, Putterman C. 2008. The novel role of neutrophil gelatinase-B associated lipocalin (NGAL)/Lipocalin-2 as a biomarker for lupus nephritis. Autoimmun Rev 7: 229-234.
47. Shen F, Ruddy MJ, Plamondon P, Gaffen SL. 2005. Cytokines link osteoblasts and inflammation: Microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J Leukoc Biol 77: 388-399.
48. Stirling DP, Liu S, Kubes P, Yong VW. 2009. Depletion of Ly6G/Gr-1 leukocytes after spinal cord injury in mice alters wound healing and worsens neurological outcome. J Neurosci 29: 753-764.
49. Stirling DP, Yong VW. 2008. Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry. J Neurosci Res 86: 1944-1958.
50. Suk K, Kim SY, Kim H. 2002. Essential role of caspase-11 in activation-induced cell death of rat astrocytes. J Neurochem 80: 230-238.
51. Sun D, Whitaker JN, Huang Z, Liu D, Coleclough C, Wekerle H, Raine CS. 2001. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 166: 7579-7587.
52. Takuma K, Baba A, Matsuda T. 2004. Astrocyte apoptosis: Implications for neuroprotection. Prog Neurobiol 72: 111-127.
53. Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD, Owens T. 1998. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 161: 3767-3775.
54. Tveita AA, Rekvig OP, Zykova SN. 2008. Increased glomerular matrix metalloproteinase activity in murine lupus nephritis. Kidney Int 74: 1150-1158.
55. Ubogu EE, Cossoy MB, Ransohoff RM. 2006. The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol Sci 27: 48-55.
56. Xu S, Venge P. 2000. Lipocalins as biochemical markers of disease. Biochim Biophys Acta 1482: 298-307.
57. Yan L, Borregaard N, Kjeldsen L, Moses MA. 2001. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 276: 37258-37265.
58. Yong VW, Zabad RK, Agrawal S, Goncalves Dasilva A, Metz LM. 2007. Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators. J Neurol Sci 259: 79-84.
59. Zhang J, Wu Y, Zhang Y, Leroith D, Bernlohr DA, Chen X. 2008. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol 22: 1416-1426.
60. Ziemssen T, Ziemssen F. 2005. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Autoimmun Rev 4: 460-467.